Targeted Toxin Gene Therapy Of Breast Cancer Stem Cells Using CXCR1 Promoter And bFGF 5′UTR

BACKGROUND: Breast cancer stem cells (BCSCs) are cells with a higher ability to metastasis and resistance to conventional treatments. They have a phenotype of (CD44high/CD24low) and the unlimited ability for proliferation. Development of strategies to target the BCSC population may lead to the estab...

Descripción completa

Detalles Bibliográficos
Autores principales: Moradian, Cobra, Rahbarizadeh, Fatemeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821057/
https://www.ncbi.nlm.nih.gov/pubmed/31695436
http://dx.doi.org/10.2147/OTT.S221223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821057/
https://www.ncbi.nlm.nih.gov/pubmed/31695436
http://dx.doi.org/10.2147/OTT.S221223

Ejemplares similares